Nuwellis Taps NeueHealth Finance Executive as CFO Amid Growth Push
Event summary
- Nuwellis appoints Carisa Schultz as CFO effective February 2, 2026.
- Schultz previously served as VP of Finance at NeueHealth (ex-Bright Health Group).
- She brings healthcare finance experience from Boston Scientific and Big Four accounting.
- Nuwellis focuses on precision cardiorenal care technologies.
The big picture
Nuwellis' appointment of a seasoned healthcare finance executive as CFO signals strategic focus on scaling its cardiorenal platform. The move comes amid increasing competition in medical technology, where precision care solutions are gaining traction. Schultz's experience with public companies and corporate development suggests Nuwellis is prioritizing operational discipline alongside growth.
What we're watching
- Execution Risk
- Whether Schultz's public company finance experience can accelerate Nuwellis' commercialization strategy.
- Growth Strategy
- How her corporate development background will shape Nuwellis' expansion in precision cardiorenal care.
- Market Positioning
- The pace at which Nuwellis can increase physician acceptance of its fluid management technologies.
Our editorial coverage: